ArticleCancer chemotherapy and pharmacology2018

Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancer.

James D Byrne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.